Jeff Brink, Strategic advisor to AiPi, is an entrepreneur and executive known for leadership,strategic thinking, and innovation. Over the last 25 years, he has successfully launched, built, and sold companies in the services and technology sectors in both the U.S. and Europe. Jeff has extensive experience with fundraising, M&A, and helping early-stage companies reach the next level. In addition to his role at AiPi, Jeff serves as Chairman of BIG Language Solutions, advises multiple early- stage companies, and sits on numerous boards.
Krim Natirbov is an international business consultant. He is Managing Director of Natir Associates LLC which advises companies on international business development and strategy. The firm’s clients include start-ups in fintech, cybersecurity, biotech, and logistics.
Krim has lived in five countries from Europe to the Middle East. He is an avid reader of History and received his BA in World History from the University of California, Santa Cruz.
Dr. Raminderpal Singh
Dr. Raminderpal Singh is a recognised KOL (key opinion leader) in the techbio industry. He has over 30 years of global experience – leading and advising teams building computational modeling systems that are both cost-efficient and have significant IP value. His passion is to help early to mid-stage life sciences companies achieve novel biological breakthroughs through the effective use of computational algorithms.
Raminderpal is currently the CEO and co-Founder of Incubate bio – a techbio providing a service to life sciences companies who are looking to accelerate their research and lower their wet lab costs through in silico modeling. Incubate bio’s technology (ALaSCA) applies causal analysis and machine learning to uncover drivers in biological systems (such as protein networks), using multi-omics and phenotypic (and clinical) data. Raminderpal also advises several early-stage life sciences and healthtech startups.
Raminderpal has extensive experience building businesses in both Europe and the US. As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge.
Raminderpal earned his PhD in semiconductor modeling in 1997. He has published several papers and two books, and he has twelve issued patents. In 2003, he was selected by EETimes as one of the top 13 most influential people in the semiconductor industry.
Charles R. Work
Charles R. Work is the former head of the McDermott Will & Emery LLP Litigation Department, the former head of that Firm’s Regulation and Government Affairs Department, and was the Partner-In-Charge of the Washington, D.C. office from 1983 to 1997. Chuck is the former outside general counsel of the AeA, formerly known as the American Electronics Association, and the former general counsel of the Intellectual Property Owners Association.
Chuck has handled civil and criminal matters in state and federal courts as well as matters before various federal agencies, including the International Trade Commission, the Federal Trade Commission, the Securities and Exchange Commission and the Office of the Independent Counsel. Chuck is a former president of the D.C. Bar, a former deputy administrator of the Law Enforcement Assistant Administration (nominated by the President and confirmed by the Senate) and a former Assistant U.S. Attorney in the District of Columbia.
Chuck served as the president’s appointee to the D.C. Commission on Judicial Tenure and Disabilities, the body that reappoints and disciplines the judges of the District of Columbia, from 1985 to 1999. Chuck has appeared in Best Lawyers in America in all editions since 1995. Chuck received a J.D. from University of Chicago Law School, LL.M. from Georgetown University Law Center, and B.A. from Wesleyan University.
Jeff has been an influential and respected presence on Wall Street for the last 30 years. Prior to founding Theia Analytics Group, Jeff was the co- founder of VogelHood Research. Jeff began his career at Donaldson, Lufkin & Jenrette in institutional sales. At C.J. Lawrence he became the youngest Director of institutional sales trading and ultimately Senior Vice President of US sales trading, responsible for all major institutional accounts. Later, at Dillon Read, Jeff served as Senior Vice President of US equity sales trading.
During his fifteen years as Managing Director of US sales trading at Fox-Pitt, Kelton, Jeff was integral to the firm’s growth from 40 to 400 employees and its ultimate global ranking as the #1 financial equity research firm in the world, leading to its acquisition by Swiss Re in 1999. Jeff later moved to Sterne Agee where he built and managed their US institutional equity platform for six years.
Throughout Jeff’s Wall Street career he has covered all major institutional clients, his focus has always been and will continue to be providing the highest level of client service.
George is a tech executive, founder, and consultant for growth companies and non-profits, specializing in creating transformative initiatives. He was founding VP Business Development of Amazon.com and helped turn Amazon from an upstart US bookseller into an international e-commerce destination. George grew Amazon’s Business Development group and oversaw strategic partnerships, including with AOL, Yahoo, and Netscape. George was instrumental in growing Amazon’s customer base from 300,000 to 11 million customers, and yearly revenues from $15 million to c. $1.5 billion in 2 years.
George has worked directly with both Jeff Bezos and Priceline founder Jay Walker, and is a named inventor on several US patents covering streaming media system technologies. George focuses on creating and growing foundational new business lines through innovative strategies, business development, marketing, innovation, growth strategies, brand management, and partnerships.